Aprea Therapeutics Inc (APRE)

3.69 +0.32 (+9.50%) USD  |  NASDAQ  |  Dec 27, 10:01
More

Aprea Therapeutics Price to Book Value: 0.9137 for Dec. 27, 2024

Price to Book Value Chart

View Price to Book Value for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 2.612
Palatin Technologies Inc --
iBio Inc 1.257
Theriva Biologics Inc 0.1616
Oragenics Inc 3.125

Price to Book Value Related Metrics

Price 3.69
Earnings Yield -76.15%
Market Cap 20.05M